Lexeo Therapeutics, Inc. (LXEO) Retained Earnings (2022 - 2023)
Lexeo Therapeutics' Retained Earnings history spans 2 years, with the latest figure at -$167.7 million for Q3 2023.
- For Q3 2023, Retained Earnings changed N/A year-over-year to -$167.7 million; the TTM value through Sep 2023 reached -$167.7 million, changed N/A, while the annual FY2022 figure was -$115.4 million, N/A changed from the prior year.
- Retained Earnings for Q3 2023 was -$167.7 million at Lexeo Therapeutics, down from -$115.4 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$115.4 million in Q4 2022 and bottomed at -$167.7 million in Q3 2023.